Our team at nCode, augmented by the ThinkHat Venture Studio, comprises visionary scientists, innovative thinkers, strategic planners, and skilled mathematicians. Together, we drive breakthroughs that transform RNA therapeutics and advance precision medicine.
"nCode is a transformative force in RNA therapeutics. The innovative Sequence as a Service (SQAAS) platform equips our clients with unparalleled predictability in clinical outcomes while leapfrogging their discovery and development timelines. The advanced AI and deep learning technologies ensure that nCode’s RNA sequences are precision controlled for cell type selectivity, expression and immunogenicity. Collaborating with nCode represents a paradigm shift for RNA therapeutic initiatives, enhancing precision and efficiency in therapeutic development. Partnering with nCode will be a game-changer for RNA therapeutic initiatives."
